[Protocol for inducing infliximab tolerance in a patient with psoriatic spondylarthritis]

MeSH terms

• Adult
• Anti-Inflammatory Agents / therapeutic use
• Antibodies, Monoclonal / administration & dosage*
• Antibodies, Monoclonal / adverse effects
• Antibodies, Monoclonal / therapeutic use
• Arthritis, Psoriatic / drug therapy*
• Chlorpheniramine / therapeutic use
• Desensitization, Immunologic*
• Drug Administration Schedule
• Flushing / chemically induced
• Flushing / prevention & control
• Histamine H1 Antagonists / therapeutic use
• Humans
• Immunologic Factors / administration & dosage*
• Immunologic Factors / adverse effects
• Immunologic Factors / therapeutic use
• Infliximab
• Infusions, Intravenous
• Male
• Methylprednisolone / therapeutic use
• Premedication
• Spondylarthritis / drug therapy*
• Sweating / drug effects
• Tumor Necrosis Factor-alpha / antagonists & inhibitors
• Vomiting / chemically induced
• Vomiting / prevention & control